Inventor · disambiguated record
Wei Yin
Also filed as: YIN WEI · YIN WEI-KUN
11 granted patents·12 pending applications·27 citations·filing 1997–2023
83Inventor score
Files withGUANGZHOU CELLPROTEK PHARM CO LTD6RANOK THERAPEUTICS HANGZHOU CO LTD6GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD3ASTRAZENECA AB1DEV CENTER FOR BIOTECHNOLOY1
Top patents by PatentIndex Score
23 records- 0180US11667629B2Isoxazole derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 6, 2023·2 cites·16 claims
- 0276US10835539B2Neuro-protective agents and uses thereofGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2019·Granted Nov 17, 2020·1 cites·6 claims
- 0375US11234968B2Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Feb 1, 2022·1 cites·12 claims
- 0473US12319750B2Hexokinase 2-specific inhibitors for use in acute central nervous system injuryGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·3 claims
- 0573US11584802B2Hexokinase 2-specific inhibitors for use in acute central nervous system injuryGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Feb 21, 2023·1 cites·3 claims
- 0671US5886185APolyamine-linked acridine dimersDEV CENTER FOR BIOTECHNOLOY·Filed 1997·Granted Mar 23, 1999·22 cites·16 claims
- 0762US2025213547A1Methods of treating neurological diseasesTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0857US2024116950A1Inhibitors of kras(g12d)RANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2023·Application pending·0 cites
- 0956US2024279316A1Compositions and methods for treating alpha-synucleinopathiesASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1056US2023365595A1Inhibitors of kras(g12d)RANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1154US11981616B2Method for preparing 3,3′-diaminobenzidineHUBEI HUIDA HIGH TECH CO LTD·Filed 2022·Granted May 14, 2024·0 cites·10 claims
- 1253US10980850B2Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 20, 2021·0 cites·13 claims
- 1349US11911396B2Use of compound in preparation of drug for treating cerebral small vessel diseaseGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Feb 27, 2024·0 cites·14 claims
- 1449US11382921B2Use of compounds in preparation of a medicament for treatment of hemorrhagic strokeGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2018·Granted Jul 12, 2022·0 cites·18 claims
- 1549US2025018047A1Methods and compositions for targeted protein degradationRANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2022·Application pending·0 cites
- 1647US2023310441A1Treatment for schizophreniaTAKEDA PHARMACEUTICAL·Filed 2021·Application pending·0 cites
- 1746US2024124460A1Methods and compositions for targeted protein degradationRANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1846US2023391792A1Methods and compositions for targeted protein degradationRANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 1946US2023391772A1Methods and compositions for targeted protein degradationRANOK THERAPEUTICS HANGZHOU CO LTD·Filed 2021·Application pending·0 cites
- 2046US2023295159A1Atx inhibitor, and preparation method therefor and use thereofSUZHOU ARK BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2141US2019183948A1Use of bcl-xl inhibitor and oncolytic virus in preparation of antitumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 2239US2010152150A1The application of marine steroid in preparing the medicine of treating neurons damagingYAN GUANGMEI·Filed 2006·Application pending·0 cites
- 2331US10357500B2Neuro-protective agents and uses thereofGUANGZHOU CELLPROTEK PHARM CO LTD·Filed 2015·Granted Jul 23, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Wei Yin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →